0001193125-22-156134 Sample Contracts

STOKE THERAPEUTICS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • May 20th, 2022 • Stoke Therapeutics, Inc. • Pharmaceutical preparations • New York

Stoke Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.